Route 92 Medical Full Length 046 Reperfusion System and Aspiration Tubing Set
Route 92 Medical, Inc. · Decision date Oct 16, 2026
What did the FDA decide?
Route 92 Medical, Inc. received a substantially equivalent (SESE) decision for the Full Length 046 Reperfusion System and Aspiration Tubing Set under 510(k) K263266. FDA recorded the decision on 2026-10-16, with the application received 09/18/2026. The device is classified as a Catheter, Thrombus Retriever under regulation 870.1250, product code NRY, with Cardiovascular as the regulation medical specialty and Neurology as the review panel. The submission was a Special 510(k), not reviewed by a third party, and no Predetermined Change Control Plan was authorized.
SESE means FDA cleared the submission as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The source data do not include the predicate device, the specific components or changes covered by this Special 510(k), or any indications for use, so the scope of the clearance beyond the device name and classification remains unknown. No summary statement content is present in the provided records.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263266
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Route 92 Medical, Inc.
- Product code
- NRY
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Thrombus Retriever.
- Applicant
- Route 92 Medical, Inc.
- Product code
- NRY
- FDA device class
- 2
FDA decision timeline
K263266 received
Application receipt date recorded by FDA.
K263266 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NRY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Toro Neurovascular, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
| Maduro Medical, Inc. | 510(k) clearance | Sep 14, 2026 | FDA | |
| Rapid-Medical , Ltd. | 510(k) clearance | Aug 28, 2026 | FDA | |
| Cerenovus, Inc. | 510(k) clearance | Aug 13, 2026 | FDA | |
| Alembic, LLC | 510(k) clearance | Aug 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Route 92 Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Mateo, CA
Sources and methodology
- Original FDA record: K263266
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
